Search clinical trials for: Benazepril/hydrochlorothiazide 20/12.5 mg - Dose Level 1 from Day 1 to Month 1
Total 33 results
-
NovartisTerminatedHypertensionUnited States, Denmark, Finland, Norway, Sweden
-
MorphoSys AGClinigen Healthcare LtdApproved for marketing
-
Novartis PharmaceuticalsEuropean and Developing Countries Clinical Trials Partnership (EDCTP); Medicines... and other collaboratorsActive, not recruitingPlasmodium Falciparum MalariaBurkina Faso, Congo, The Democratic Republic of the
-
Jazz PharmaceuticalsCompletedEpilepsy | Dravet SyndromeUnited States, United Kingdom
-
Boehringer IngelheimCompletedHypertensionFrance, Switzerland, Italy, Germany, Hong Kong, Netherlands, South Africa, Spain, Taiwan, Denmark, Sweden, Finland, Ireland, Korea, Republic of, Malaysia, Norway
-
Latin American Cooperative Oncology GroupMerck Sharp & Dohme LLCActive, not recruitingSquamous Cell Carcinoma of LarynxBrazil
-
Assiut UniversityUnknownImmune ThrombocytopeniaEgypt
-
National Heart, Lung, and Blood Institute (NHLBI)NovartisRecruitingSevere Aplastic AnemiaUnited States
-
University of Roma La SapienzaUnknownCoronary Artery DiseaseItaly
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Rush University Medical CenterCompletedNausea | VomitingUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Gilead SciencesCompletedHepatitis CUnited States, Puerto Rico
-
Hospital for Special Surgery, New YorkCompletedTotal Hip ReplacementUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Michigan; University of North Carolina, Chapel HillCompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
Yuhan CorporationNot yet recruitingEssential HypertensionKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompletedLeukemia | Acute Lymphoblastic LeukemiaUnited States
-
Assistance Publique - Hôpitaux de ParisAventis PharmaceuticalsCompletedEHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT | CHROMOSOME 2q31.2 DELETION SYNDROME
-
Jazz PharmaceuticalsCompletedEpilepsySpain, United Kingdom
-
PfizerCompleted
-
University of Texas Southwestern Medical CenterNational Center for Research Resources (NCRR)CompletedPulmonary Arterial HypertensionUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsCompletedCardiovascular Diseases | Coronary Disease | Hypertension | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Atherosclerosis | HypercholesterolemiaUnited States, Canada
-
Poitiers University HospitalCompletedKidney TransplantationFrance
-
National Hepatology & Tropical Medicine Research...CompletedHepato-Renal SyndromeEgypt
-
Memorial Sloan Kettering Cancer CenterBoehringer Ingelheim; National Comprehensive Cancer NetworkCompletedHead and Neck Cancer | Squamous Cell CancerUnited States
-
University of Texas Southwestern Medical CenterCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedAcute Myeloid Leukemia | Advanced Myelodysplastic SyndromesUnited States
-
Medical College of WisconsinCompletedAcute Myeloid LeukemiaUnited States
-
Ramathibodi HospitalCompletedRadical MastectomyThailand
-
University of UtahBoston University; University of Pennsylvania; Northwestern University; Columbia... and other collaboratorsCompleted
-
Ukrainian Medical Stomatological AcademyCompletedAdverse Effect | Atherosclerosis, Coronary | Insulin Resistance SyndromeUkraine
-
UMC UtrechtNational University Hospital, Singapore; Berry Consultants; University of Pittsburgh... and other collaboratorsRecruitingCommunity-acquired Pneumonia, Influenza, COVID-19United Kingdom, United States, Canada, Australia, Netherlands, Croatia, Germany, Belgium, New Zealand, Ireland, Spain, Japan, Hungary, Colombia, India, Nepal, Pakistan, Portugal, Romania, Saudi Arabia